TWO SIGMA INVESTMENTS, LP - BIOSPECIFICS TECHNOLOGIES CO ownership

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q2 2019$782,000
-31.9%
13,094
-33.4%
0.00%0.0%
Q3 2018$1,149,000
+54.0%
19,646
+18.1%
0.00%
+50.0%
Q2 2018$746,000
-6.4%
16,635
-7.5%
0.00%
-33.3%
Q1 2018$797,000
+12.7%
17,976
+10.1%
0.00%
+50.0%
Q4 2017$707,000
+118.9%
16,325
+135.1%
0.00%
+100.0%
Q3 2017$323,000
-28.4%
6,943
-23.7%
0.00%
-50.0%
Q2 2017$451,000
-47.4%
9,105
-41.9%
0.00%
-33.3%
Q1 2017$858,000
-45.0%
15,658
-44.1%
0.00%
-50.0%
Q4 2016$1,561,000
-17.9%
28,027
-32.7%
0.01%
-14.3%
Q3 2016$1,902,000
+19.8%
41,640
+4.8%
0.01%0.0%
Q2 2016$1,588,000
+0.7%
39,751
-12.2%
0.01%
-12.5%
Q1 2016$1,577,000
+150.3%
45,292
+208.7%
0.01%
+166.7%
Q4 2015$630,000
-58.3%
14,672
-49.9%
0.00%
-57.1%
Q2 2015$1,512,000
+96.4%
29,297
+48.9%
0.01%
+75.0%
Q1 2015$770,000
-46.5%
19,679
-47.2%
0.00%
-50.0%
Q4 2014$1,439,000
+267.1%
37,266
+235.7%
0.01%
+300.0%
Q3 2014$392,000
+66.1%
11,100
-8.3%
0.00%0.0%
Q3 2013$236,00012,1110.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 385,954$16,723,00010.02%
JW Asset Management, LLC 73,649$3,191,0003.40%
Elk Creek Partners, LLC 168,714$7,310,0000.43%
NORTHPOINTE CAPITAL LLC 80,710$3,497,0000.39%
Ativo Capital Management LLC 33,096$1,434,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 155,318$6,730,0000.26%
ISTHMUS PARTNERS, LLC 17,406$754,0000.20%
Matarin Capital Management, LLC 48,952$2,121,090,0000.16%
GLOBEFLEX CAPITAL L P 4,324$187,0000.05%
Summit Trail Advisors, LLC 6,797$295,0000.04%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders